1 hr ago | Bloomberg
Merck, Pfizer Back Lawmakers Who Oppose Company Products
There was plenty of debate about the new health-care law in the 2010 congressional elections while little, if any, on birth control .
6 hrs ago | WJCW-AM Gray
FDA Slaps J&J for Tampon, KY Trouble
The beleaguered consumer product giant Johnson & Johnson has had its hand slapped again by the FDA, this time for problems with tampons and other popular personal care products.
7 hrs ago | WDBO-AM Orlando
Fearing a financial rupture in Europe, investors around the world fled from risk Wednesday.
11 hrs ago | Patch.com
Virtual Town Hall Questions for Dennis Ridz
Patch: Share a short bio about yourself: Ridz: Education - BS in Accounting, Masters in Finance, Masters in Chemical Industrial Studies in the Pharmaceutical Field and almost 20 years in Senior Management with Johnson and Johnson.
14 hrs ago | Bladen Journal
The Cape Fear Farmers Market features local farmer-grown, local farmer-sold products.
19 hrs ago | Forbes.com
Facebook's Fall: Slide Carves $21B Off Market Cap In 7 Trading Days
When Facebook went public May 18 its offering tipped the scales at $16 billion, the second-largest U.S. IPO on record.
23 hrs ago | The Motley Fool
2 Big Dividends to Drive Your Retirement Portfolio
The single, easiest way to keep track of all the stocks that matter... Your own personalized stock watchlist! It's a 100% FREE Motley Fool service... Last summer, I pledged to put at least $4,000 of my own money behind 10 stocks.
Janssen and Johnson & Johnson to Provide Webcast Presentation of ZYTIGA
Results from pre-specified interim analyses of COU-AA-302, a randomized, phase 3 study of abiraterone acetate in chemotherapy-naive patients with metastatic castration-resistant prostate cancer, will be shown for the first time at ASCO.
Johnson & Johnson's McNeil unit receives criticism from FDA on quality control procedures
The Food and Drug Administration, in a May 22 letter, criticized McNeil Consumer Products for violating regulations on quality control procedures.
Us Fda warns J&J unit about tampon complaints
U.S. drug regulators chided a Johnson & Johnson unit for not reporting or investigating customer complaints about O.B. Tampons or personal lubricants similar to K-Y Jelly.
4 Pharmaceuticals To Buy Now For Profits In 2013
Ranked among some of the largest businesses across the globe, Johnson & Johnson caters to a global market, manufacturing and selling medical and pharmaceutical products.
Alumna gives second $1 million gift
Half of the $1 million commitment will be used as an unrestricted gift, and the other half for math and science scholarships.
Mercedes, Apple leading brands in India
Jobs Commodities Automobiles Insurance Real Estate Travel & Tourism Health & Pharma Lifestyle Media Power Telecom Infotech Retail Infrastructure Editor's Picks New Delhi : Indian consumers have a strong desire for brands that embody success and achievement and have a particular liking for luxury, technology and media brands like Mercedes, Apple, ... (more)
Five Stocks Hedge Funds are Betting Against
Goldman Sachs released a report highlighting the companies with the largest short positions among hedge funds.
3 Reasons To Buy Johnson & Johnson
Johnson & Johnson shares have pulled back with the markets and now can be bought near the 52-week lows.
5 Stocks For The Do It Yourself Dividend Juggernaut
Dividend investors demand safety, income, and absolute returns from their income portfolio.
Biotechnology Stocks To Watch Ahead Of ASCO 2012: Part 4
This is a continuation of my previous article on biotechnology stocks to watch ahead of ASCO 2012.
The Best Dogs Of The Dow Jones As Of May 2012
T -0.06% VZ +0.14% MRK -0.24% PFE -0.45% GE -1.23% JNJ -1% PG -0.14% DD -0.53% CVX -1.35% JPM -1.67% Dogs of the Dow Jones by Dividend Yield - Stock, Capital, Investment .
Have J&J's Approval Hopes Vanished?
The single, easiest way to keep track of all the stocks that matter... Your own personalized stock watchlist! It's a 100% FREE Motley Fool service... ) Xarelto -- the blood thinner is already approved to prevent blood clots after surgery and to treat arterial fibrillation, a type of irregular heart beat -- but it could be the most important.
Stephen H. Guth Settles SEC Insider Trading Charge Concerning Omrix Tender Offer
The U.S. Securities and Exchange Commission today filed a settled civil injunctive action in the U.S. District Court for the District of Columbia alleging that Stephen H. Guth violated Section 14 of the Securities Exchange Act of 1934 and Rule 14e-3 promulgated thereunder, by buying Omrix Biopharmaceuticals, Inc.